Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-04

FDA Approved: FAMOTIDINE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves Amneal's original application for famotidine, enabling a generic version of the H2 blocker. The approval covers common indications associated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)